APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pathological Examination

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.

Selected research

Market Outlook & Growth Opportunities

Global Pathological Examination Market Outlook and Growth Opportunities 2026

Report ID 173895090428 December 2025190 pages

Choose your research edition.

Industry ResearchPathological Examination Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathological Examination Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pathological Examination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathological Examination Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathological Examination Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.

From perspective of type, pathological examination can be split into histopathology, cell pathology, immunohistochemical pathology and molecular pathology. In 2019, cell pathology took up for about 48% market share, which made it the largest segment of global pathological examination.

North America is the largest consumption region of pathological examination, with a consumption market share nearly 37% in 2019. The second place is Asia-Pacific; following North America with the consumption market share over 31% in 2020.

Read the full market overview

Key players of global pathological examination market are Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International. The top 5 players totally took up a market share of about 18% in 2019. Quest Diagnostics is in the first place, which accounted for above 5% of global market.

This report provides an overview of the global Pathological Examination market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pathological Examination and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pathological Examination revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathological Examination market.

Pathological Examination Segment by Company

Quest Diagnostics

Sonic Healthcare

Lab Corp

Unilabs

SYNLAB International

BML

Pathologists Diagnostic

StageBio

KingMed Diagnostics Group

Dian Diagnostics Group

Adicon Clinical Laboratories Inc.

Huayin Health

Pathological Examination Segment by Type

Histopathology

Cytopathology

Immunohistochemical Pathology

Molecular Pathology

Pathological Examination Segment by Application

Hospital

Medical Laboratory

Pathological Examination Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pathological Examination status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pathological Examination key companies, revenue, market share, and recent developments.

3. To split the Pathological Examination breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pathological Examination market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pathological Examination significant trends, drivers, influence factors in global and regions.

6. To analyze Pathological Examination competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathological Examination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathological Examination and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathological Examination.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathological Examination industry.

Chapter 3: Detailed analysis of Pathological Examination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pathological Examination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pathological Examination in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pathological Examination Industry Trends Table 2. Pathological Examination Industry Drivers Table 3. Pathological Examination Industry Opportunities and Challenges Table 4. Pathological Examination Industry Restraints Table 5. Global Pathological Examination Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pathological Examination Revenue Share by Company (2021-2026) Table 7. Global Pathological Examination Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pathological Examination Key Company Manufacturing Base & Headquarters Table 9. Global Pathological Examination Company, Product Type & Application Table 10. Global Pathological Examination Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pathological Examination by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Histopathology Table 15. Significant Companies of Cytopathology Table 16. Significant Companies of Immunohistochemical Pathology Table 17. Significant Companies of Molecular Pathology Table 18. Global Pathological Examination Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pathological Examination Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pathological Examination Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pathological Examination Sales Value Share by Type (2021-2026) Table 22. Global Pathological Examination Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Medical Laboratory Table 25. Global Pathological Examination Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pathological Examination Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pathological Examination Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pathological Examination Sales Value Share by Application (2021-2026) Table 29. Global Pathological Examination Sales Value Share by Application (2027-2032) Table 30. Global Pathological Examination Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pathological Examination Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pathological Examination Sales Value Share by Region (2021-2026) Table 33. Global Pathological Examination Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pathological Examination Sales Value Share by Region (2027-2032) Table 35. Global Pathological Examination Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pathological Examination Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pathological Examination Sales Value Market Share by Country (2021-2026) Table 38. Global Pathological Examination Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pathological Examination Sales Value Market Share by Country (2027-2032) Table 40. Quest Diagnostics Company Information Table 41. Quest Diagnostics Business Overview Table 42. Quest Diagnostics Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Quest Diagnostics Pathological Examination Product Portfolio Table 44. Quest Diagnostics Recent Development Table 45. Sonic Healthcare Company Information Table 46. Sonic Healthcare Business Overview Table 47. Sonic Healthcare Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Sonic Healthcare Pathological Examination Product Portfolio Table 49. Sonic Healthcare Recent Development Table 50. Lab Corp Company Information Table 51. Lab Corp Business Overview Table 52. Lab Corp Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Lab Corp Pathological Examination Product Portfolio Table 54. Lab Corp Recent Development Table 55. Unilabs Company Information Table 56. Unilabs Business Overview Table 57. Unilabs Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Unilabs Pathological Examination Product Portfolio Table 59. Unilabs Recent Development Table 60. SYNLAB International Company Information Table 61. SYNLAB International Business Overview Table 62. SYNLAB International Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. SYNLAB International Pathological Examination Product Portfolio Table 64. SYNLAB International Recent Development Table 65. BML Company Information Table 66. BML Business Overview Table 67. BML Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BML Pathological Examination Product Portfolio Table 69. BML Recent Development Table 70. Pathologists Diagnostic Company Information Table 71. Pathologists Diagnostic Business Overview Table 72. Pathologists Diagnostic Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Pathologists Diagnostic Pathological Examination Product Portfolio Table 74. Pathologists Diagnostic Recent Development Table 75. StageBio Company Information Table 76. StageBio Business Overview Table 77. StageBio Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. StageBio Pathological Examination Product Portfolio Table 79. StageBio Recent Development Table 80. KingMed Diagnostics Group Company Information Table 81. KingMed Diagnostics Group Business Overview Table 82. KingMed Diagnostics Group Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. KingMed Diagnostics Group Pathological Examination Product Portfolio Table 84. KingMed Diagnostics Group Recent Development Table 85. Dian Diagnostics Group Company Information Table 86. Dian Diagnostics Group Business Overview Table 87. Dian Diagnostics Group Pathological Examination Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Dian Diagnostics Group Pathological Examination Product Portfolio Table 89. Dian Diagnostics Group Recent Development Table 90. Adicon Clinical Laboratories Inc. Company Information Table 91. Adicon Clinical Laboratories Inc. Business Overview Table 92. Adicon Clinical Laboratories Inc. Pathological Examination Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 93. Adicon Clinical Laboratories Inc. Pathological Examination Product Portfolio Table 94. Adicon Clinical Laboratories Inc. Recent Development Table 95. Huayin Health Company Information Table 96. Huayin Health Business Overview Table 97. Huayin Health Pathological Examination Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 98. Huayin Health Pathological Examination Product Portfolio Table 99. Huayin Health Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Pathological Examination Product Image Figure 2. Global Pathological Examination Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathological Examination Market Size (2021-2032) & (US$ Million) Figure 4. Global Pathological Examination Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Histopathology Image Figure 8. Cytopathology Image Figure 9. Immunohistochemical Pathology Image Figure 10. Molecular Pathology Image Figure 11. Global Pathological Examination Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pathological Examination Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pathological Examination Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Medical Laboratory Image Figure 16. Global Pathological Examination Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pathological Examination Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pathological Examination Sales Value Share by Application (2021-2032) Figure 19. Global Pathological Examination Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pathological Examination Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pathological Examination Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pathological Examination Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pathological Examination Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pathological Examination Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pathological Examination Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pathological Examination Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pathological Examination Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pathological Examination Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pathological Examination Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pathological Examination Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pathological Examination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pathological Examination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pathological Examination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Histopathology
  • Cytopathology
  • Immunohistochemical Pathology
  • Molecular Pathology
Applications
  • Hospital
  • Medical Laboratory
Companies covered
  • Quest Diagnostics
  • Sonic Healthcare
  • Lab Corp
  • Unilabs
  • SYNLAB International
  • BML
  • Pathologists Diagnostic
  • StageBio
  • KingMed Diagnostics Group
  • Dian Diagnostics Group
  • Adicon Clinical Laboratories Inc.
  • Huayin Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pathological Examination Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pathological Examination Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pathological Examination Market Dynamics
  1. 2.1 Pathological Examination Industry Trends
  2. 2.2 Pathological Examination Industry Drivers
  3. 2.3 Pathological Examination Industry Opportunities and Challenges
  4. 2.4 Pathological Examination Industry Restraints
3 Pathological Examination Market by Company
  1. 3.1 Global Pathological Examination Company Revenue Ranking in 2025
  2. 3.2 Global Pathological Examination Revenue by Company (2021-2026)
  3. 3.3 Global Pathological Examination Company Ranking (2024-2026)
  4. 3.4 Global Pathological Examination Company Manufacturing Base and Headquarters
  5. 3.5 Global Pathological Examination Company Product Type and Application
  6. 3.6 Global Pathological Examination Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pathological Examination Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pathological Examination Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pathological Examination Market by Type
  1. 4.1 Pathological Examination Type Introduction
  2. 4.1.1 Histopathology
  3. 4.1.2 Cytopathology
  4. 4.1.3 Immunohistochemical Pathology
  5. 4.1.4 Molecular Pathology
  6. 4.2 Global Pathological Examination Sales Value by Type
  7. 4.2.1 Global Pathological Examination Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pathological Examination Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pathological Examination Sales Value Share by Type (2021-2032)
5 Pathological Examination Market by Application
  1. 5.1 Pathological Examination Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Medical Laboratory
  4. 5.2 Global Pathological Examination Sales Value by Application
  5. 5.2.1 Global Pathological Examination Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pathological Examination Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pathological Examination Sales Value Share by Application (2021-2032)
6 Pathological Examination Regional Value Analysis
  1. 6.1 Global Pathological Examination Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pathological Examination Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pathological Examination Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pathological Examination Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pathological Examination Sales Value (2021-2032)
  7. 6.3.2 North America Pathological Examination Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pathological Examination Sales Value (2021-2032)
  10. 6.4.2 Europe Pathological Examination Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pathological Examination Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pathological Examination Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pathological Examination Sales Value (2021-2032)
  16. 6.6.2 South America Pathological Examination Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pathological Examination Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pathological Examination Sales Value Share by Country, 2025 VS 2032
7 Pathological Examination Country-level Value Analysis
  1. 7.1 Global Pathological Examination Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pathological Examination Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pathological Examination Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pathological Examination Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pathological Examination Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pathological Examination Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pathological Examination Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pathological Examination Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pathological Examination Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pathological Examination Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pathological Examination Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pathological Examination Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pathological Examination Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pathological Examination Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pathological Examination Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pathological Examination Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pathological Examination Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pathological Examination Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pathological Examination Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pathological Examination Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pathological Examination Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pathological Examination Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pathological Examination Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pathological Examination Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pathological Examination Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pathological Examination Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pathological Examination Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pathological Examination Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pathological Examination Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pathological Examination Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pathological Examination Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pathological Examination Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pathological Examination Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pathological Examination Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pathological Examination Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pathological Examination Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pathological Examination Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pathological Examination Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pathological Examination Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pathological Examination Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pathological Examination Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pathological Examination Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pathological Examination Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pathological Examination Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pathological Examination Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pathological Examination Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pathological Examination Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pathological Examination Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pathological Examination Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pathological Examination Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pathological Examination Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pathological Examination Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pathological Examination Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pathological Examination Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pathological Examination Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pathological Examination Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pathological Examination Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pathological Examination Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pathological Examination Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pathological Examination Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pathological Examination Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pathological Examination Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pathological Examination Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pathological Examination Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pathological Examination Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pathological Examination Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pathological Examination Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pathological Examination Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pathological Examination Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pathological Examination Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pathological Examination Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pathological Examination Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pathological Examination Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pathological Examination Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pathological Examination Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pathological Examination Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pathological Examination Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pathological Examination Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pathological Examination Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pathological Examination Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pathological Examination Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pathological Examination Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pathological Examination Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pathological Examination Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pathological Examination Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pathological Examination Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pathological Examination Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pathological Examination Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics
  2. 8.1.1 Quest Diagnostics Company Information
  3. 8.1.2 Quest Diagnostics Business Overview
  4. 8.1.3 Quest Diagnostics Pathological Examination Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Pathological Examination Product Portfolio
  6. 8.1.5 Quest Diagnostics Recent Developments
  7. 8.2 Sonic Healthcare
  8. 8.2.1 Sonic Healthcare Company Information
  9. 8.2.2 Sonic Healthcare Business Overview
  10. 8.2.3 Sonic Healthcare Pathological Examination Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sonic Healthcare Pathological Examination Product Portfolio
  12. 8.2.5 Sonic Healthcare Recent Developments
  13. 8.3 Lab Corp
  14. 8.3.1 Lab Corp Company Information
  15. 8.3.2 Lab Corp Business Overview
  16. 8.3.3 Lab Corp Pathological Examination Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lab Corp Pathological Examination Product Portfolio
  18. 8.3.5 Lab Corp Recent Developments
  19. 8.4 Unilabs
  20. 8.4.1 Unilabs Company Information
  21. 8.4.2 Unilabs Business Overview
  22. 8.4.3 Unilabs Pathological Examination Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Unilabs Pathological Examination Product Portfolio
  24. 8.4.5 Unilabs Recent Developments
  25. 8.5 SYNLAB International
  26. 8.5.1 SYNLAB International Company Information
  27. 8.5.2 SYNLAB International Business Overview
  28. 8.5.3 SYNLAB International Pathological Examination Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SYNLAB International Pathological Examination Product Portfolio
  30. 8.5.5 SYNLAB International Recent Developments
  31. 8.6 BML
  32. 8.6.1 BML Company Information
  33. 8.6.2 BML Business Overview
  34. 8.6.3 BML Pathological Examination Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BML Pathological Examination Product Portfolio
  36. 8.6.5 BML Recent Developments
  37. 8.7 Pathologists Diagnostic
  38. 8.7.1 Pathologists Diagnostic Company Information
  39. 8.7.2 Pathologists Diagnostic Business Overview
  40. 8.7.3 Pathologists Diagnostic Pathological Examination Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pathologists Diagnostic Pathological Examination Product Portfolio
  42. 8.7.5 Pathologists Diagnostic Recent Developments
  43. 8.8 StageBio
  44. 8.8.1 StageBio Company Information
  45. 8.8.2 StageBio Business Overview
  46. 8.8.3 StageBio Pathological Examination Revenue and Gross Margin (2021-2026)
  47. 8.8.4 StageBio Pathological Examination Product Portfolio
  48. 8.8.5 StageBio Recent Developments
  49. 8.9 KingMed Diagnostics Group
  50. 8.9.1 KingMed Diagnostics Group Company Information
  51. 8.9.2 KingMed Diagnostics Group Business Overview
  52. 8.9.3 KingMed Diagnostics Group Pathological Examination Revenue and Gross Margin (2021-2026)
  53. 8.9.4 KingMed Diagnostics Group Pathological Examination Product Portfolio
  54. 8.9.5 KingMed Diagnostics Group Recent Developments
  55. 8.10 Dian Diagnostics Group
  56. 8.10.1 Dian Diagnostics Group Company Information
  57. 8.10.2 Dian Diagnostics Group Business Overview
  58. 8.10.3 Dian Diagnostics Group Pathological Examination Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dian Diagnostics Group Pathological Examination Product Portfolio
  60. 8.10.5 Dian Diagnostics Group Recent Developments
  61. 8.11 Adicon Clinical Laboratories Inc.
  62. 8.11.1 Adicon Clinical Laboratories Inc. Company Information
  63. 8.11.2 Adicon Clinical Laboratories Inc. Business Overview
  64. 8.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Product Portfolio
  66. 8.11.5 Adicon Clinical Laboratories Inc. Recent Developments
  67. 8.12 Huayin Health
  68. 8.12.1 Huayin Health Company Information
  69. 8.12.2 Huayin Health Business Overview
  70. 8.12.3 Huayin Health Pathological Examination Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Huayin Health Pathological Examination Product Portfolio
  72. 8.12.5 Huayin Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst